Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Aurobindo Pharma Ltd
Press Release Dec 27 2022
Business
Dec 27 2022
3 min read

Press Release Dec 27 2022

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 27, 2022, titled "Tergene Biotech Pvt. Ltd., a Joint Venture company, receives SEC recommendation for pneumococcal 15 valent (PCV15) vaccine.".

View Attachment